Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) – Analysts at William Blair raised their FY2026 earnings per share estimates for shares of Cellebrite DI in a report issued on Thursday, August 15th. William Blair analyst J. Ho now expects that the company will post earnings of $0.54 per share for the year, up from their prior forecast of $0.53. The consensus estimate for Cellebrite DI’s current full-year earnings is $0.38 per share. William Blair also issued estimates for Cellebrite DI’s FY2027 earnings at $0.62 EPS and FY2028 earnings at $0.72 EPS.
Cellebrite DI (NASDAQ:CLBT – Get Free Report) last posted its earnings results on Thursday, August 15th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Cellebrite DI had a negative net margin of 28.51% and a positive return on equity of 515.14%. The firm had revenue of $95.70 million during the quarter, compared to analyst estimates of $91.94 million. During the same period last year, the firm posted $0.05 earnings per share. Cellebrite DI’s revenue for the quarter was up 24.8% compared to the same quarter last year.
Check Out Our Latest Analysis on Cellebrite DI
Cellebrite DI Stock Up 2.5 %
Cellebrite DI stock opened at $16.78 on Monday. The company’s 50-day moving average price is $12.85 and its 200-day moving average price is $11.69. The company has a market cap of $3.46 billion, a PE ratio of -28.93, a price-to-earnings-growth ratio of 1.97 and a beta of 1.50. Cellebrite DI has a twelve month low of $6.36 and a twelve month high of $16.89.
Hedge Funds Weigh In On Cellebrite DI
Several hedge funds have recently bought and sold shares of the business. IGP Investments G.P.L.P LP purchased a new stake in shares of Cellebrite DI during the fourth quarter valued at $182,619,000. Pembroke Management LTD boosted its position in Cellebrite DI by 104.9% in the 2nd quarter. Pembroke Management LTD now owns 1,535,726 shares of the company’s stock valued at $18,352,000 after buying an additional 786,310 shares during the period. Scalar Gauge Management LLC bought a new position in Cellebrite DI in the 4th quarter worth about $5,914,000. Acadian Asset Management LLC increased its position in shares of Cellebrite DI by 26.8% during the first quarter. Acadian Asset Management LLC now owns 2,896,497 shares of the company’s stock worth $32,062,000 after acquiring an additional 612,787 shares during the period. Finally, Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Cellebrite DI by 7.8% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 7,086,158 shares of the company’s stock valued at $56,446,000 after acquiring an additional 514,858 shares in the last quarter. Institutional investors own 45.88% of the company’s stock.
Cellebrite DI Company Profile
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.
Read More
- Five stocks we like better than Cellebrite DI
- Golden Cross Stocks: Pattern, Examples and Charts
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- What does consumer price index measure?
- Lowe’s Stock: Hold Now, Buy it When it Dips
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.